Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Grant Ellsworth, MD, MS
Weill Medical College of Cornell University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universidade de São Paulo
São Paulo, São Paulo, Brazil
- Instituto Nacional de Salud Pública, Mexico
Cuernavaca, Morelos, Mexico
- University of Puerto Rico Aids Clinical Trials Unit
San Juan, Purto Rico, Puerto Rico
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Feb 2021
- Primary completion
- 31 Jul 2026
- Completion
- 31 Jul 2026
- Last update posted
- 18 Jun 2026
- Registered enrollment
- 700
- Registry id
- NCT04255849
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.